在患有急性髓性白血病的患者中,Venotoclax相关的甲状腺功能低下症
Uğur Can İzlimek1, Barış Karagün2, Emel Gürkan3
1Department of Internal Medicine, Cukurova Medical School, Adana, Turkey.
概括
作为BCL2抑制剂的Venetoclax可以导致甲状腺功能低下. 这份病例报告详细介绍了一名患者在接受venetoclax和azacitidine治疗时发展出非自身免疫性甲状腺功能障碍.
科学领域:
- 血液学 血液学 血液学
- 内分泌学 在内分泌学.
- 在瘤学瘤学.
背景情况:
- 维内托克拉克斯是一种BCL2抑制剂,用于治疗某些血液性恶性瘤.
- 与低甲基化剂 (HMA) 联合治疗是常见的,但可能会产生副作用.
- 甲状腺功能障碍以前没有报告与venetoclax.
研究的目的:
- 报告与venetoclax治疗相关的甲状腺功能低下病例.
- 在这种情况下,研究甲状腺功能障碍的潜在机制.
- 为了强调在venetoclax治疗期间甲状腺监测的重要性.
主要方法:
- 一个62岁的女性患有复发性/耐药性AML的病例报告.
- 治疗包括阿扎西提丁和venetoclax.
- 进行了甲状腺功能测试,甲状腺超声波和自身抗体评估.
主要成果:
- 患者在治疗开始后一个月内出现甲状腺功能低下症.
- 甲状腺功能测试显示TSH升高和FT4低.
- 甲状腺自身抗体呈阴性,超声波显示甲状腺扩大扩散.
结论:
- 威尼托克拉克斯可能与罕见的非自身免疫性甲状腺功能障碍有关.
- 缺少自身抗体表明,除了自身免疫性甲状腺炎之外,还有一种机制.
- 建议对接受venetoclax的患者进行定期的甲状腺功能监测.
相关概念视频
Disorders of Leukocytes
732
Leukocyte disorders can lead to either leukopenia, characterized by an abnormally low leukocyte count, or leukocytosis, marked by a very high leukocyte number.
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
Leukopenia may result from bone marrow disorders, autoimmune diseases, and infectious diseases. For example, conditions such as multiple myeloma and aplastic anemia can impair the bone marrow's ability to produce adequate leukocytes. Similarly, autoimmune diseases like lupus and viral infections such as HIV can prompt the immune...
732
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
185
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
185
Bone Marrow Sampling and Transplants
263
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
263
Renal Failure: Dose Adjustments
37
In patients with renal impairment, drugs undergo significant changes in their pharmacokinetics, which require dosage adjustments to ensure safe and effective therapy.
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
Reduced renal clearance and elimination rate are common outcomes of renal impairment. These alterations lead to a prolonged elimination half-life and an altered apparent volume of distribution for drugs. As a result, dosage adjustments are typically necessary to maintain optimal drug levels in the body.
However, dosage adjustments...
37
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
105
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
105


